Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival
2009

Heat Shock Proteins in Gastric Cancer

Sample size: 66 publication Evidence: moderate

Author Information

Author(s): Giaginis Constantinos, Daskalopoulou Stella S, Vgenopoulou Stephanie, Sfiniadakis Ioannis, Kouraklis Gregorios, Theocharis Stamatios E

Primary Institution: Medical School, University of Athens, Athens, Greece

Hypothesis

The study aimed to evaluate the clinical significance of HSP -27, -60, and -90 expression in gastric carcinoma.

Conclusion

HSP-27, -60, and -90 were associated with certain clinicopathological parameters crucial for managing gastric adenocarcinoma patients, with HSP-90 expression identified as an independent prognostic indicator.

Supporting Evidence

  • HSP-27 expression was significantly associated with tumor size, organ metastases, and pStage.
  • HSP-60 expression was significantly associated with patients' sex.
  • HSP-90 expression was significantly associated with longer overall survival times.

Takeaway

This study looked at special proteins in stomach cancer and found that one of them, HSP-90, can help doctors understand how long patients might live.

Methodology

The expression of HSP -27, -60, and -90 proteins was assessed immunohistochemically in tumor samples from 66 gastric adenocarcinoma patients.

Participant Demographics

47 men (71%) and 19 women (29%), mean age 67.5 years.

Statistical Information

P-Value

P = 0.026 for HSP-27 with tumor size

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-230X-9-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication